Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development.
about
Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical ImplicationsEpigenetic control of the tumor microenvironment.The biomarkers of leukemia stem cells in acute myeloid leukemia.Targeting multiple nodes of MLL complexes to improve leukemia therapy.Expression of multiple leukemic stem cell markers is associated with poor prognosis in de novo acute myeloid leukemia.The Lysine Demethylase dKDM2 Is Non-essential for Viability, but Regulates Circadian Rhythms in
P2860
Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Epigenetic therapies by target ...... ical and clinical development.
@en
type
label
Epigenetic therapies by target ...... ical and clinical development.
@en
prefLabel
Epigenetic therapies by target ...... ical and clinical development.
@en
P2860
P921
P356
P1433
P1476
Epigenetic therapies by target ...... ical and clinical development.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2016.315
P407
P5008
P577
2016-09-05T00:00:00Z
2017-03-30T00:00:00Z
P6179
1012203106